RXO, Inc.
28.75USD
-0.1700 (-0.59%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on RXO.
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 4.8B | 3.9B | 4.6B | 5.7B | 6.9B | 7.5B |
| Q1 | 1.3B | 1.0B | 913.0M | 1.4B | 1.4B | — |
| Q2 | 1.2B | 963.0M | 930.0M | 1.4B | 1.8B | — |
| Q3 | 1.1B | 976.0M | 1.0B | 1.4B | 1.8B | — |
| Q4 | 1.1B* | 978.0M* | 1.7B* | 1.5B* | 1.8B | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | .790 | .030 | -2.17 | -.590 | .145 | .654 |
| Q1 | .340 | .000 | -.130 | -.180 | -.210 | — |
| Q2 | .380 | .030 | -.060 | -.050 | -.050 | — |
| Q3 | .110 | -.010 | -1.81 | -.080 | .075 | — |
| Q4 | -.035* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
Revenue to net income
| .017* |
| -.187* |
| -.273* |
| .091 |
| — |
Debt level and coverage